We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Expro Ltd
XPRO
$1.96B
| $3.7K | ﹤0.01% |
+209
| New | +$3.77K |
|
1927
PLAYSTUDIOS Inc
MYPS
$59.1M
| $3.68K | ﹤0.01% |
+750
| New | +$3.28K |
|
1928
Navitas Semiconductor
NVTS
$2.82B
| $3.67K | ﹤0.01% |
+348
| New | +$2.69K |
|
1929
Oric Pharmaceuticals
ORIC
$1.28B
| $3.62K | ﹤0.01% |
467
+324
| +227% | +$1.84K |
|
1930
CRH
CRH
$58.3B
| $3.62K | ﹤0.01% |
65
-53
| -45% | -$2.65K |
|
|
CELL
1931
DELISTED
PhenomeX Inc. Common Stock
CELL
| $3.58K | ﹤0.01% |
7,304
-156,183
| -96% | -$128K |
|
1932
HSBC
HSBC
$350B
| $3.53K | ﹤0.01% |
89
-25
| -22% | -$933 |
|
1933
Cabaletta Bio
CABA
$441M
| $3.52K | ﹤0.01% |
+273
| New | +$2.96K |
|
1934
Disc Medicine
IRON
$2.58B
| $3.46K | ﹤0.01% |
+78
| New | +$2.77K |
|
1935
Champion Homes
SKY
$4.59B
| $3.4K | ﹤0.01% |
52
-974
| -95% | -$66.2K |
|
|
ARC
1936
DELISTED
ARC Document Solutions, Inc.
ARC
| $3.33K | ﹤0.01% |
1,029
-109
| -10% | -$327 |
|
1937
Raymond James Financial
RJF
$32.5B
| $3.32K | ﹤0.01% |
32
-67,141
| -100% | -$6.23M |
|
1938
Caesarstone
CSTE
$104M
| $3.3K | ﹤0.01% |
629
+528
| +523% | +$2.39K |
|
1939
Heritage Insurance Holdings
HRTG
$1.03B
| $3.3K | ﹤0.01% |
+856
| New | +$3.44K |
|
|
NTST
1940
NETSTREIT Corp
NTST
$1.96B
| $3.23K | ﹤0.01% |
+181
| New | +$3.25K |
|
1941
Village Super Market
VLGEA
$653M
| $3.22K | ﹤0.01% |
141
-15
| -10% | -$326 |
|
1942
Toyota
TM
$231B
| $3.21K | ﹤0.01% |
20
-36
| -64% | -$5.18K |
|
|
EXPR
1943
DELISTED
Express, Inc.
EXPR
| $3.2K | ﹤0.01% |
+270
| New | +$3.92K |
|
1944
Design Therapeutics
DSGN
$765M
| $3.2K | ﹤0.01% |
508
-133
| -21% | -$814 |
|
1945
Oil States International
OIS
$519M
| $3.2K | ﹤0.01% |
428
-42
| -9% | -$307 |
|
1946
Virco
VIRC
$97.4M
| $3.17K | ﹤0.01% |
761
| – | – |
|
1947
Medifast
MED
$134M
| $3.04K | ﹤0.01% |
33
-9
| -21% | -$801 |
|
|
CODX
1948
Co-Diagnostics
CODX
$7.96M
| $3.03K | ﹤0.01% |
+91
| New | +$3.48K |
|
1949
Brookfield Renewable
BEPC
$5.39B
| $2.99K | ﹤0.01% |
95
+90
| +1,800% | +$3.04K |
|
1950
Momentus
MNTS
$88.3M
| $2.99K | ﹤0.01% |
1
| – | – |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.